Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check5 days agoChange Detected- Added revision v3.4.3 to the Record History and removed v3.4.2, updating the page to reflect the latest revision.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now includes a new entry, Revision: v3.4.2, and older notices (including the funding notice and Revision: v3.4.1) have been removed.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a government funding notice and a new page revision entry v3.4.1; removed the previous revision entry v3.4.0.SummaryDifference0.6%

- Check48 days agoChange DetectedThe patch adds a glossary toggle, introduces green highlights for additions and red highlights for deletions, and updates the revision label from v3.3.4 to v3.4.0 with minor wording adjustments.SummaryDifference0.8%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the study record history, and revision v3.3.3 was removed to reflect the latest updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the Record History and removed the old 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' entry.SummaryDifference0.2%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.